Financial Stewardship

Preserving The Public Trust

Transparency, Accountability, Stewardship

When you donate to OCRA, you can be sure your money is handled responsibly. By ensuring rigorous accountability, financial transparency, and meticulous stewardship of our donors’ funds, OCRA has earned the highest possible rating from Charity Navigator and a Gold rating from Guidestar. We also meet the stringent Standards for Charity Accountability set forth by the Better Business Bureau’s Wise Giving Alliance.

Please explore this page to view our financial statements and policies.

Financial Statements

Ovarian Cancer Research Alliance is a 501(c) 3 non profit organization. Our financial documents are public and available for viewing below.

Financial Statements from Ovarian Cancer Research Alliance:

2022: Form 990 | Financial Statement | 2022 Annual Report
2021: Form 990 | Financial Statement | 2021 Annual Report
2020: Form 990 | Financial Statement | 2020 Annual Report
2019: Form 990 | Financial Statement | 2019 Annual Report
2018: Form 990 | Financial Statement | 2018 Annual Report
2017: Form 990 | Financial Statement | 2017 Annual Report
2016: Form 990 | Financial Statement

Financial Statements from the former Ovarian Cancer Research Fund:

Financial Statements from the former Ovarian Cancer National Alliance:

Policies

A 501(c)(3) organization, Ovarian Cancer Research Alliance receives funding from individual donors, foundations, corporations, and cause-marketing initiatives. Individual solicitations, direct mail, fundraising events, grant proposals, sponsorships, product sales, and special projects secure these funds.

Our mission is to remain objective in providing information to the ovarian cancer community; we do not endorse any particular treatment, therapy, clinical trial or product.

Ovarian Cancer Research Alliance is committed to:

Ensuring that fundraising complies with all applicable federal and state regulations, including appropriate registrations, annual filings, and audits to comply with the Internal Revenue Code;
Providing the public with access to its most recent financial reports and filings;
Maintaining the confidentiality of donors’ information and ensuring any disclosures comply with all applicable laws;
Accepting contributions from sources such as individuals, foundations, and for-profit institutions while ensuring that the positions of Ovarian Cancer Research Alliance on policy issues are never unduly or improperly influenced by contributors.

Conflict of Interest Statement — Industry Partners

Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
In 2023, industry partners represented 14% of OCRA’s overall revenue.
No industry personnel serve on OCRA’s governing board (Board of Directors).
If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.

Read our conflict of interest policy